Dr. Richard Maiman, MD, FACS

In 2023, Dr. Richard Maiman, MD, FACS performed more injections, inpatient hospital care (for patient admitted to hospital), and minimally invasive procedures procedures for Medicare patients than 95% of providers in related specialties within New York.

In 2023, among providers in related specialties within New York, Dr. Richard Maiman, MD, FACS performed more hormone therapy, indwelling urethral catheter insertion, lab tests, neurostimulation, and percutaneous tibial nerve stimulation (PTNS) procedures for Medicare patients than 90% of them and he also had a list price for blood draw, susceptibility testing, and venipuncture (phlebotomy) that was lower than the list prices billed to Medicare by 90% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

In 2013, among providers in related specialties within New York, Dr. Richard Maiman, MD, FACS performed more biopsy, blood draw, core needle prostate biopsy, cystoscopic stone removal, cystoscopy, cystoscopy with foreign body removal, cystoscopy with ureteral stent placement, cystoscopy with ureteral stent removal, phlebotomy for lab tests, potassium sensitivity test, prostate biopsy, prostate punch biopsy, ureteroscopy with laser lithotripsy, and urologic procedures procedures for Medicare patients than 75% of them and he also had a list price for blood draw for lab tests, hormone replacement therapy, hormone therapy, intravenous (IV) infusion, phlebotomy for lab tests, post void residual study, prostate screening, screening PSA test, testosterone injections, testosterone therapy, urinalysis, and urine culture that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.